Jury Awards $2.5 Million in Risperdal Trial
Posted on: March 14, 2016 Risperdal Lawsuits
The Wall Street Journal reported that a Philadelphia jury held Johnson & Johnson (J&J) liable for failing to warn that its antipsychotic drug Risperdal could cause gynecomastia and ordered the company to pay $2.5 million in damages. The family of an autistic boy who took Risperdal between 2002 and 2006 and later developed size 46DD breasts brought the suit, claiming J&J hid the risks of male breast development with the use of Risperdal in young boys and men. While J&J settled a number of these claims over the past few years, this was the first one to go to trial where J&J was accused of hiding data from the U.S. Food and Drug Administration as well as prescribing doctors and parents. One law school professor from the University of Richmond commented that the verdict “doesn’t bode well for the company,” but cautioned that J&J would most likely want to see more jury verdicts before seriously considering settlement negotiations for the 1,200 similar lawsuits filed against the company. For its part, J&J said it would consider its options going forward, including a possible appeal of the verdict.
Learn More About Risperdal Lawsuits
The Feeney Law Firm provides additional information about dangerous drugs on our Risperdal lawsuit page. Our law firm is dedicated to those who have been affected by Risperdal. If you or a loved one has suffered serious injuries due to Risperdal, then call us immediately at 1-800-366-6577 for your FREE consult. You may be entitled to compensation, so do not delay. Your time to file a claim may be limited.